Latest news
Latest news
Norton Rose Fulbright and Katten have added to their legal teams
Asset manager wants to offer more products to institutional investors
More articles
More articles
-
BondWeek is the leading news publication for fixed-income professionals, covering new deals, structures, asset-backed securities, industry and market activity.
-
BondWeek is the leading news publication for fixed-income professionals, covering new deals, structures, asset-backed securities, industry and market activity.
-
BondWeek is the leading news publication for fixed-income professionals, covering new deals, structures, asset-backed securities, industry and market activity.
-
BondWeek is the leading news publication for fixed-income professionals, covering new deals, structures, asset-backed securities, industry and market activity.
-
BondWeek is the leading news publication for fixed-income professionals, covering new deals, structures, asset-backed securities, industry and market activity.
-
BondWeek is the leading news publication for fixed-income professionals, covering new deals, structures, asset-backed securities, industry and market activity.
-
BondWeek is the leading news publication for fixed-income professionals, covering new deals, structures, asset-backed securities, industry and market activity.
-
BondWeek is the leading news publication for fixed-income professionals, covering new deals, structures, asset-backed securities, industry and market activity.
-
Quintiles Transnational Corp. is moving along in setting up approval for its $1.7 billion buyout by Pharma Services Holdings, but the company has still not provided word on the status of the financing for the transaction. The pharmaceutical research and marketing firm said in its second quarter earnings conference call earlier this month that it hopes to hold a shareholder meeting to vote on the merger in the third quarter of this year. Sources said company officials did not address questions regarding the financing status during the conference call. Greg Connors, v.p. of investor relations, and a company spokeswoman did not return calls before press time.